Baruch L - Search Results

1

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT).

Baruch L, Glazer RD, Aknay N, Vanhaecke J, Heywood JT, Anand I, Krum H, Hester A, Cohn JN. Baruch L, et al. Am Heart J. 2004 Dec;148(6):951-7. doi: 10.1016/j.ahj.2004.06.001. Am Heart J. 2004. PMID: 15632877 Clinical Trial.

2

Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group.

Baruch L, Anand I, Cohen IS, Ziesche S, Judd D, Cohn JN. Baruch L, et al. Circulation. 1999 May 25;99(20):2658-64. doi: 10.1161/01.cir.99.20.2658. Circulation. 1999. PMID: 10338459 Clinical Trial.

3

Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial).

Majahalme SK, Baruch L, Aknay N, Goedel-Meinen L, Hofmann M, Hester A, Prescott MF, Feliciano N; Val-HeFT Study Investigators. Majahalme SK, et al. Among authors: baruch l. Am J Cardiol. 2005 Feb 15;95(4):529-32. doi: 10.1016/j.amjcard.2004.10.026. Am J Cardiol. 2005. PMID: 15695147 Clinical Trial.

4

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.

Cohn JN, Ziesche S, Smith R, Anand I, Dunkman WB, Loeb H, Cintron G, Boden W, Baruch L, Rochin P, Loss L. Cohn JN, et al. Among authors: baruch l. Circulation. 1997 Aug 5;96(3):856-63. doi: 10.1161/01.cir.96.3.856. Circulation. 1997. PMID: 9264493 Clinical Trial.

5

Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change.

Wong M, Germanson T, Taylor WR, Cohen IS, Perry G, Baruch L, Deedwania P, Lopez B, Cohn JN. Wong M, et al. Among authors: baruch l. J Card Fail. 2000 Mar;6(1):19-28. doi: 10.1016/s1071-9164(00)00008-7. J Card Fail. 2000. PMID: 10746815 Clinical Trial.

6

Beta-blockers in heart failure: is more better?

Baruch L, Kunamneni P. Baruch L, et al. Curr Heart Fail Rep. 2004 Jul;1(2):77-81. doi: 10.1007/s11897-004-0030-7. Curr Heart Fail Rep. 2004. PMID: 16036029 Review.

7

Pharmacodynamic effects of milrinone with and without a bolus loading infusion.

Baruch L, Patacsil P, Hameed A, Pina I, Loh E. Baruch L, et al. Am Heart J. 2001 Feb;141(2):266-73. doi: 10.1067/mhj.2001.111404. Am Heart J. 2001. PMID: 11174341 Clinical Trial.

8

The role of angiotensin receptor blockers in heart failure.

Baruch L, Jamil T. Baruch L, et al. Congest Heart Fail. 2000 Mar-Apr;6(2):103-109. doi: 10.1111/j.1527-5299.2000.80138.x. Congest Heart Fail. 2000. PMID: 12029195 Free article.

9

Hypertension and the elderly: more than just blood pressure control.

Baruch L. Baruch L. J Clin Hypertens (Greenwich). 2004 May;6(5):249-55. doi: 10.1111/j.1524-6175.2004.03307.x. J Clin Hypertens (Greenwich). 2004. PMID: 15133407 Free PMC article. Review.

10

Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart Failure.

Lopez PD, Bhatia K, Bohra C, Mahmood K, Baruch L, Eng C. Lopez PD, et al. Among authors: baruch l. Am J Cardiol. 2022 Oct 15;181:87-93. doi: 10.1016/j.amjcard.2022.07.012. Epub 2022 Aug 11. Am J Cardiol. 2022. PMID: 35963825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters